IMC Chicago’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.76M Sell
23,400
-3,800
-14% -$531K ﹤0.01% 2296
2025
Q4
$4.46M Buy
27,200
+16,700
+159% +$2.62M ﹤0.01% 1818
2025
Q3
$1.4M Buy
+10,500
New +$1.28M ﹤0.01% 2483
2025
Q2
Sell
-13,100
Closed -$1.67M 3540
2025
Q1
$1.67M Sell
13,100
-16,700
-56% -$2.57M ﹤0.01% 1925
2024
Q4
$4.29M Buy
29,800
+2,400
+9% +$344K ﹤0.01% 1336
2024
Q3
$4.08M Buy
27,400
+8,000
+41% +$1.15M ﹤0.01% 1232
2024
Q2
$2.45M Buy
+19,400
New +$3.04M ﹤0.01% 1446

Other funds holding RGEN

IMC Chicago's RGEN Position: Q1 2026 in Review

IMC Chicago opened a new position in Repligen (RGEN) in Q1 2026: 9,012 shares worth $1.06M. The stake represents ﹤0.01% of the portfolio and ranks #3226 among its holdings.

441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • IMC Chicago held 9,012 shares of Repligen worth $1.06M as of Q1 2026.
  • Repligen was a new IMC Chicago position in Q1 2026.
  • Repligen made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3226 holding.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.